P53 biomarkers
US10883993B2 · kind B2 · utility
0Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2017 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Mar 26, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to the identification of p53 biomarker profiles that predict response in patients with hyperproliferative disease such as cancer to a therapy, and their use in methods of treating such patients with an anti-hyperproliferative disease gene therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.